These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23791500)

  • 21. Functional alginate nanoparticles for efficient intracellular release of doxorubicin and hepatoma carcinoma cell targeting therapy.
    Guo H; Lai Q; Wang W; Wu Y; Zhang C; Liu Y; Yuan Z
    Int J Pharm; 2013 Jul; 451(1-2):1-11. PubMed ID: 23618965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resveratrol-loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles: Preparation, characterization, and targeting effect on liver tumors.
    Wu M; Lian B; Deng Y; Feng Z; Zhong C; Wu W; Huang Y; Wang L; Zu C; Zhao X
    J Biomater Appl; 2017 Aug; 32(2):191-205. PubMed ID: 28610486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.
    Shi L; Tang C; Yin C
    Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1.
    Zhai JM; Yin XY; Lai YR; Hou X; Cai JP; Hao XY; Liang LJ; Zhang LJ
    Cancer Chemother Pharmacol; 2013 May; 71(5):1255-64. PubMed ID: 23435877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
    Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
    Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sorafenib-Entrapped, Self-Assembled Pullulan-Stearic Acid Biopolymer-Derived Drug Delivery System to PLC/PRF/5 Hepatocellular Carcinoma Model.
    Chirayil TJ; Kumar GSV
    Int J Nanomedicine; 2022; 17():5099-5116. PubMed ID: 36340185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced immunotherapy of SM5-1 in hepatocellular carcinoma by conjugating with gold nanoparticles and its in vivo bioluminescence tomographic evaluation.
    Ma X; Hui H; Jin Y; Dong D; Liang X; Yang X; Tan K; Dai Z; Cheng Z; Tian J
    Biomaterials; 2016 May; 87():46-56. PubMed ID: 26897539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistically killing activity of aspirin and histone deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer cells.
    Li X; Zhu Y; He H; Lou L; Ye W; Chen Y; Wang J
    Biochem Biophys Res Commun; 2013 Jun; 436(2):259-64. PubMed ID: 23726914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivo.
    Hossain MA; Kim DH; Jang JY; Kang YJ; Yoon JH; Moon JO; Chung HY; Kim GY; Choi YH; Copple BL; Kim ND
    Int J Oncol; 2012 May; 40(5):1636-42. PubMed ID: 22322725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma.
    Xu Z; Chen L; Gu W; Gao Y; Lin L; Zhang Z; Xi Y; Li Y
    Biomaterials; 2009 Jan; 30(2):226-32. PubMed ID: 18851881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A theranostic system based on nanocomposites of manganese oxide nanoparticles and a pH sensitive polymer: Preparation, and physicochemical characterization.
    Samiei Foroushani M; Niroumand N; Karimi Shervedani R; Yaghoobi F; Kefayat A; Torabi M
    Bioelectrochemistry; 2019 Dec; 130():107347. PubMed ID: 31437809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combretastatin A4 Nanoparticles Combined with Hypoxia-Sensitive Imiquimod: A New Paradigm for the Modulation of Host Immunological Responses during Cancer Treatment.
    Shen N; Wu J; Yang C; Yu H; Yang S; Li T; Chen J; Tang Z; Chen X
    Nano Lett; 2019 Nov; 19(11):8021-8031. PubMed ID: 31558024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid lipid nanoparticles of anticancer drugs against MCF-7 cell line and a murine breast cancer model.
    Zhuang YG; Xu B; Huang F; Wu JJ; Chen S
    Pharmazie; 2012 Nov; 67(11):925-9. PubMed ID: 23210242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study.
    Ghous Z; Akhter J; Pourgholami MH; Morris DL
    Anticancer Res; 2008; 28(6A):3757-61. PubMed ID: 19189661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pH-responsive hyaluronic acid nanoparticles coloaded with sorafenib and cisplatin for treatment of hepatocellular carcinoma.
    Zhang W; Cai J; Wu B; Shen Z
    J Biomater Appl; 2019 Aug; 34(2):219-228. PubMed ID: 31084233
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preparation of doxorubicin encapsulated in amphiphilic polysaccharide nanoparticles and anti-hepatocarcinoma effect thereof].
    Huang YF; Gu WL; Li ZH; Chen RF; Zhou JJ; Zhou QB; Guo N
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):810-2. PubMed ID: 19595118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivery of Arsenic Trioxide by Multifunction Nanoparticles To Improve the Treatment of Hepatocellular Carcinoma.
    Wu Q; Chen X; Wang P; Wu Q; Qi X; Han X; Chen L; Meng X; Xu K
    ACS Appl Mater Interfaces; 2020 Feb; 12(7):8016-8029. PubMed ID: 31997633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.